Pharmaceutical Patent Term Extensions

Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents

June 16, 2020 2:30pm

Event Contacts

Partnership Opportunities

C5 Communications

Email Us

Speaking Opportunities

C5 Communications

Email Us

Sponsorship Opportunities

C5 Communications

Email Us

Join Our Mailing List

Receive exclusive discounts, offers and agenda updates directly to your inbox.